191 related articles for article (PubMed ID: 15690969)
1. Erythropoietin requirement in patients with type 2 diabetes mellitus on maintenance hemodialysis therapy.
Biesenbach G; Schmekal B; Eichbauer-Sturm G; Janko O
Wien Klin Wochenschr; 2004 Dec; 116(24):844-8. PubMed ID: 15690969
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
3. [Role of iron deficiency in erythropoietin sensitivity in dialysis patients with elevated C-reactive protein].
Martone M; Zanchi R; Panzetta G
G Ital Nefrol; 2003; 20(1):31-7. PubMed ID: 12647284
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
Pilkey RM; Morton AR; Iliescu EA
Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
[TBL] [Abstract][Full Text] [Related]
5. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials].
Pljesa S
Med Pregl; 2007; 60(3-4):123-7. PubMed ID: 17853722
[TBL] [Abstract][Full Text] [Related]
6. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
Sultana T; DeVita MV; Michelis MF
Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
8. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload.
Lin CL; Hsu PY; Yang HY; Huang CC
Ren Fail; 2003 May; 25(3):445-53. PubMed ID: 12803508
[TBL] [Abstract][Full Text] [Related]
9. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
Park L; Uhthoff T; Tierney M; Nadler S
Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194
[TBL] [Abstract][Full Text] [Related]
10. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease.
Schwartz DI; Pierratos A; Richardson RM; Fenton SS; Chan CT
Clin Nephrol; 2005 Mar; 63(3):202-8. PubMed ID: 15786821
[TBL] [Abstract][Full Text] [Related]
11. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
12. The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
Musanovic A; Trnacevic S; Mekic M; Musanovic A
Med Arch; 2013; 67(5):361-4. PubMed ID: 24601173
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients].
Nesić V; Ostrić V; Kovacević Z; Dimković N; Curić S; Lazarević M; Ratković M; Bogdanović J; Jelacić R
Med Pregl; 2005; 58(5-6):279-85. PubMed ID: 16526235
[TBL] [Abstract][Full Text] [Related]
15. Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection.
Altintepe L; Kurtoglu E; Tonbul Z; Yeksan M; Yildiz A; Türk S
Clin Nephrol; 2004 May; 61(5):347-51. PubMed ID: 15182130
[TBL] [Abstract][Full Text] [Related]
16. Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: is there a synergistic effect with insulin?
Fernandez-Reyes MJ; Selgas R; Bajo MA; Jimenez C; Del Peso G; Sanchez MC; Dapena F; De Alvaro F
Perit Dial Int; 1995; 15(6):231-5. PubMed ID: 7578499
[TBL] [Abstract][Full Text] [Related]
17. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A
Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972
[TBL] [Abstract][Full Text] [Related]
18. Hemodialysis treatment time versus erythropoietin dose requirement: Reduction in 2,000 units per week by extension of hemodialysis for 1 hour
.
Maeda A; Tsuruya K; Maeda M; Yamasaki M; Nakashima A; Nakashima Y; Date S; Maeda T; Kamijyou M; Kubara T; Hayashi W; Kitazono T
Clin Nephrol; 2019 Oct; 92(4):174-179. PubMed ID: 31272526
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients.
Shaheen FA; Souqiyyeh MZ; Akeel N
Saudi J Kidney Dis Transpl; 2002; 13(2):131-40. PubMed ID: 17660651
[TBL] [Abstract][Full Text] [Related]
20. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
Florit EA; Hadad F; Rodriguez Cubillo B; De la Flor JC; Valga F; Perez Flores I; Calvo Romero N; Valero San Cecilio R; Barrientos Guzman A; Sanchez Fructuoso A
Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
